These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11811787)

  • 21. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
    Lee SW; Park Y; Yoo JK; Choi SY; Sung YC
    J Immunol; 2003 Mar; 170(5):2456-60. PubMed ID: 12594270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.
    Mariani SM; Krammer PH
    Eur J Immunol; 1998 May; 28(5):1492-8. PubMed ID: 9603453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
    Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
    Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas ligand-mediated depletion of CD4 and CD8 lymphocytes by monomeric HIV-1-gp120.
    Uchiyama J; Kishi S; Yagita H; Matsuzaki S; Koga Y
    Arch Virol; 1997; 142(9):1771-85. PubMed ID: 9672636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.
    Frank MH; Denton MD; Alexander SI; Khoury SJ; Sayegh MH; Briscoe DM
    J Immunol; 2001 Feb; 166(4):2451-9. PubMed ID: 11160305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.
    Drach J; Gsur A; Hamilton G; Zhao S; Angerler J; Fiegl M; Zojer N; Raderer M; Haberl I; Andreeff M; Huber H
    Blood; 1996 Sep; 88(5):1747-54. PubMed ID: 8781431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.
    Smyth MJ; Krasovskis E; Sutton VR; Johnstone RW
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7024-9. PubMed ID: 9618532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.
    Yerramasetti R; Gollapudi S; Gupta S
    J Clin Immunol; 2002 Jan; 22(1):37-47. PubMed ID: 11958592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells.
    Mantovani I; Cappellini A; Tazzari PL; Papa V; Cocco L; Martelli AM
    J Cell Physiol; 2006 Jun; 207(3):836-44. PubMed ID: 16526059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction.
    Hur YG; Yun Y; Won J
    J Immunol; 2004 Jan; 172(1):79-87. PubMed ID: 14688312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
    Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
    AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
    Ceuppens JL; Van Vaeck F
    Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
    Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
    J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance.
    Ruefli AA; Smyth MJ; Johnstone RW
    Blood; 2000 Apr; 95(7):2378-85. PubMed ID: 10733510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.
    Walker LS; McLeod JD; Boulougouris G; Patel YI; Ellwood CN; Hall ND; Sansom DM
    Immunology; 1999 Dec; 98(4):569-75. PubMed ID: 10594690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.